Lupin Launches Generic Joint Pain Drug In US

Lupin's product is the generic version of Pennsaid. (Representational)

Drug firm Lupin today said it has launched a generic version of Pennsaid, used to treat pain in the knees caused by osteoarthritis in the American market.

Drug firm Lupin today said it has launched a generic version of Pennsaid, used to treat pain in the knees caused by osteoarthritis in the American market.

The company's product -- Diclofenac Sodium Topical Solution 2 per cent -- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.

As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of $509 million in the US.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

lock-gif
Register for Free
to continue reading
Sign Up with Google
OR
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.
GET REGULAR UPDATES